JPMORGAN CHASE & CO - UTAH MED PRODS INC ownership

UTAH MED PRODS INC's ticker is UTMD and the CUSIP is 917488108. A total of 86 filers reported holding UTAH MED PRODS INC in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
JPMORGAN CHASE & CO ownership history of UTAH MED PRODS INC
ValueSharesWeighting
Q3 2023$5,010,876
-8.1%
58,266
-0.5%
0.00%0.0%
Q2 2023$5,455,369
-32.6%
58,534
-31.5%
0.00%0.0%
Q1 2023$8,099,000
+96708.5%
85,468
+2.7%
0.00%0.0%
Q4 2022$8,366
-99.9%
83,213
-10.0%
0.00%0.0%
Q3 2022$7,885,000
-11.6%
92,427
-11.0%
0.00%0.0%
Q2 2022$8,918,000
-2.5%
103,814
+2.0%
0.00%0.0%
Q1 2022$9,145,000
+5.0%
101,769
+16.9%
0.00%0.0%
Q4 2021$8,708,000
+0.1%
87,076
-7.0%
0.00%0.0%
Q3 2021$8,696,000
+5.9%
93,661
-3.1%
0.00%0.0%
Q2 2021$8,215,000
+46.8%
96,619
+49.5%
0.00%0.0%
Q1 2021$5,596,000
-0.2%
64,618
-2.8%
0.00%0.0%
Q4 2020$5,606,000
+32.7%
66,500
+27.5%
0.00%0.0%
Q3 2020$4,223,000
+6.1%
52,171
+16.1%
0.00%0.0%
Q2 2020$3,981,000
+169.0%
44,920
+185.4%
0.00%
Q1 2020$1,480,000
+313.4%
15,738
+373.8%
0.00%
Q4 2019$358,000
+228.4%
3,322
+191.1%
0.00%
Q3 2019$109,000
-94.9%
1,141
-95.2%
0.00%
Q2 2019$2,132,000
+7.9%
23,549
+5.1%
0.00%
Q1 2019$1,976,000
-1.8%
22,400
-7.5%
0.00%
Q4 2018$2,012,000
-15.0%
24,218
-3.7%
0.00%
Q3 2018$2,368,000
+2.6%
25,148
+20.0%
0.00%
Q2 2018$2,308,000
-14.3%
20,950
-23.1%
0.00%
-100.0%
Q1 2018$2,694,000
+6.1%
27,253
-12.7%
0.00%0.0%
Q4 2017$2,539,000
-1.5%
31,200
-9.6%
0.00%0.0%
Q3 2017$2,577,000
+5.4%
34,518
+2.3%
0.00%0.0%
Q2 2017$2,444,000
+6.3%
33,757
-8.5%
0.00%0.0%
Q1 2017$2,299,000
-12.8%
36,908
+1.8%
0.00%0.0%
Q4 2016$2,636,000
+54.0%
36,240
+26.5%
0.00%
Q3 2016$1,712,000
+19.8%
28,638
+26.3%
0.00%
Q2 2016$1,429,000
-7.7%
22,675
-8.4%
0.00%
Q1 2016$1,548,000
+19.3%
24,750
+11.6%
0.00%
Q4 2015$1,298,000
+50.2%
22,175
+38.2%
0.00%
Q3 2015$864,00016,0500.00%
Other shareholders
UTAH MED PRODS INC shareholders Q1 2023
NameSharesValueWeighting ↓
Clean Yield Group 49,094$3,535,0001.48%
MORGAN DEMPSEY CAPITAL MANAGEMENT LLC 27,464$1,988,0000.72%
Ativo Capital Management LLC 16,525$1,196,0000.33%
Ancora Advisors LLC 55,159$3,993,0000.26%
ISTHMUS PARTNERS, LLC 10,754$779,0000.23%
Cardinal Capital Management 9,180$665,0000.22%
Acrospire Investment Management LLC 1,919$139,0000.13%
Penobscot Investment Management Company, Inc. 4,000$290,0000.09%
TFS CAPITAL LLC 3,226$234,0000.09%
WCM INVESTMENT MANAGEMENT, LLC 81,912$5,930,0000.09%
View complete list of UTAH MED PRODS INC shareholders